Cephalexin

Product NDC: 65862-018
Requested package NDC: 65862-018-22
11-digit product format: 658620018
Labeler code: 65862
Product ID: 65862-018_51110cd1-498e-42ac-87a8-dc1e9f7e732b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cephalexin
Dosage form: CAPSULE
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA065253
Marketing category: ANDA
Marketing start: 2005-11-16
Substance: CEPHALEXIN
Active strength: 250 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished package	package	65862-018	65862-018-22	UNFINISHED	Active or certified unfinished drug listing		2026-08-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A065253-001	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16
A065253-002	CEPHALEXIN	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16
A065253-003	CEPHALEXIN	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A065253-001	AB
A065253-002	AB
A065253-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 100 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065253-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-11-16	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065253-003	CEPHALEXIN	EQ 750MG BASE	CAPSULE / ORAL	AB	2023-12-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065253-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-11-16	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 100 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065253-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065253-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065253-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065253-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065253-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065253-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065253-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065253-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065253-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065253-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065253-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065253-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065253-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065253-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065253-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065253-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065253-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065253-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065253-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065253-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065253-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065253-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065253-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065253-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065253-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065253-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065253-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065253-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065253-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065253-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065253-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065253-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065253-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065253-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065253-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065253-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065253-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065253-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065253-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065253-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cephalexin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEPHALEXIN	250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
OBN7UDS42Y	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309112	Internal RxNorm lookup
309114	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
8e28f049-6110-4473-830f-c494191a7197	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dfa3f520-409c-432e-b6d3-9250d468c772	Product name	1	20250401
64bb7f1a-2c2e-4741-8301-dbfeda7239f6	Product name	1	20190628
398aa563-bb78-fe0f-46a8-757c40ef28bf	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65862-018-01	Cephalexin	100 in 1 BOTTLE	CAPSULE	100	18
65862-018-05	Cephalexin	500 in 1 BOTTLE	CAPSULE	500	18
65862-018-20	Cephalexin	20 in 1 BOTTLE	CAPSULE	20	18
65862-018-40	Cephalexin	40 in 1 BOTTLE	CAPSULE	40	18

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-018-01	EA - Each	65862-018	2f9ab1a9-c44d-4ffc-9e47-a6a7dd0bceb2	1	2012-07-24
65862-018-05	EA - Each	65862-018	1756f266-9b41-4f9d-89c7-9792037171ef	1	2012-07-24
65862-018-40	EA - Each	65862-018	02ffc6be-e98e-47a8-b8e0-093d44f64cda	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	6
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [PHYSICIANS TOTAL CARE, INC.]	5
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.]	4
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [STAT RX USA LLC]	2
CEPHALEXIN	ACTIVE MOIETY	OBN7UDS42Y	CEPHALEXIN CAPSULE [STAT RX USA LLC]	2
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
Cephalexin	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
Cephalexin	ACTIVE MOIETY	OBN7UDS42Y	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
Croscarmellose Sodium	INACTIVE INGREDIENT	M28OL1HH48	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
D&C Yellow No. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
Gelatin	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
Sodium Lauryl Sulfate	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
Titanium Dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [REBEL DISTRIBUTORS CORP.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [A-S MEDICATION SOLUTIONS LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-018	CEPHALEXIN CAPSULE [AUROBINDO PHARMA LIMITED]	18	Current NDC, Legacy NDC, 4 package rows	20241222_8e28f049-6110-4473-830f-c494191a7197.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cephalexin	CEPHALEXIN	REMEDYREPACK INC.	2506895d-f3e0-4be9-95cb-7a6fd44de46d	2026-08-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Preferred Pharmaceuticals Inc.	88426cb3-1c0c-439b-9f1a-aa169040c29f	2026-07-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Northwind Health Company, LLC	1d0d50ba-8c2c-855c-e063-6394a90a5c7d	2026-07-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	47b6bc70-e8cc-4837-a39a-6998ee4e37dc	2026-04-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	8a938dd0-fca6-4f22-9fb0-632596603001	2026-04-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Preferred Pharmaceuticals Inc.	52d8a080-eafc-46fe-82d9-6b69c6a3a38a	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Chartwell RX, LLC	d315cce8-9784-419e-818b-16d68d1dbd6e	2025-12-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	NuCare Pharmaceuticals,Inc.	0b3da88f-f513-cdf0-e063-6394a90a7205	2025-12-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	2070b988-f7fb-4e35-91e3-1b7df5e5326c	2025-11-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	AMELLA PHARMA, LLC	602fae70-3b8a-4f09-8db1-41fef4a2ecd7	2025-10-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	REMEDYREPACK INC.	c0ca008e-0e28-412e-a58f-70f63817713b	2025-09-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	f3b46058-3e53-413b-b9c9-7d49e50f861e	2025-09-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	88a744d8-a95e-4c63-8b25-52f5039b6ba1	2025-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	NuCare Pharmaceuticals,Inc.	0aad51b4-86d5-e312-e063-6394a90a250d	2025-07-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	50f0187b-09e7-4c11-970f-91cd1877fde1	2025-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	905b3270-abbd-4d5c-b313-3d20eb4b4c57	2025-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Bryant Ranch Prepack	f2e73727-2ab6-4418-9677-19ea1d140bbd	2025-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	Coupler, LLC	30b7071e-cef1-bd41-e063-6394a90ad48e	2025-03-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	NuCare Pharmaceuticals, Inc.	28da5822-fb0b-1306-e063-6394a90a6e4c	2025-03-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253
Cephalexin	CEPHALEXIN	A-S Medication Solutions	02b5cd6f-3df8-43c1-879d-217fcf55231a	2025-02-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065253 application number: ANDA065253

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OBN7UDS42Y	CEPHALEXIN	23325-78-2	CEPHALEXIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309112	cephalexin 250 MG Oral Capsule	PSN	8a938dd0-fca6-4f22-9fb0-632596603001	100
309112	cephalexin 250 MG Oral Capsule	SCD	8a938dd0-fca6-4f22-9fb0-632596603001	100
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	8a938dd0-fca6-4f22-9fb0-632596603001	100
309112	cephalexin 250 MG Oral Capsule	PSN	8e28f049-6110-4473-830f-c494191a7197	18
309114	cephalexin 500 MG Oral Capsule	PSN	8e28f049-6110-4473-830f-c494191a7197	18
309112	cephalexin 250 MG Oral Capsule	SCD	8e28f049-6110-4473-830f-c494191a7197	18
309114	cephalexin 500 MG Oral Capsule	SCD	8e28f049-6110-4473-830f-c494191a7197	18
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	8e28f049-6110-4473-830f-c494191a7197	18
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	8e28f049-6110-4473-830f-c494191a7197	18
309112	cephalexin 250 MG Oral Capsule	PSN	65b38519-1d8a-4aca-b415-c64cca84d085	17
309114	cephalexin 500 MG Oral Capsule	PSN	65b38519-1d8a-4aca-b415-c64cca84d085	17
309112	cephalexin 250 MG Oral Capsule	SCD	65b38519-1d8a-4aca-b415-c64cca84d085	17
309114	cephalexin 500 MG Oral Capsule	SCD	65b38519-1d8a-4aca-b415-c64cca84d085	17
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	65b38519-1d8a-4aca-b415-c64cca84d085	17
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	65b38519-1d8a-4aca-b415-c64cca84d085	17
309112	cephalexin 250 MG Oral Capsule	PSN	99ef59d5-bc44-4727-86fe-dc81357207c3	14
309114	cephalexin 500 MG Oral Capsule	PSN	99ef59d5-bc44-4727-86fe-dc81357207c3	14
309112	cephalexin 250 MG Oral Capsule	SCD	99ef59d5-bc44-4727-86fe-dc81357207c3	14
309114	cephalexin 500 MG Oral Capsule	SCD	99ef59d5-bc44-4727-86fe-dc81357207c3	14
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	99ef59d5-bc44-4727-86fe-dc81357207c3	14
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	99ef59d5-bc44-4727-86fe-dc81357207c3	14
309112	cephalexin 250 MG Oral Capsule	PSN	c9202158-e3e4-4efc-9cc7-58e92d7fde8d	5
309114	cephalexin 500 MG Oral Capsule	PSN	c9202158-e3e4-4efc-9cc7-58e92d7fde8d	5
309112	cephalexin 250 MG Oral Capsule	SCD	c9202158-e3e4-4efc-9cc7-58e92d7fde8d	5
309114	cephalexin 500 MG Oral Capsule	SCD	c9202158-e3e4-4efc-9cc7-58e92d7fde8d	5
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	c9202158-e3e4-4efc-9cc7-58e92d7fde8d	5
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	c9202158-e3e4-4efc-9cc7-58e92d7fde8d	5
309112	cephalexin 250 MG Oral Capsule	PSN	c6d56d5e-856e-4e48-85f7-fce2beade4d1	4
309114	cephalexin 500 MG Oral Capsule	PSN	c6d56d5e-856e-4e48-85f7-fce2beade4d1	4
309112	cephalexin 250 MG Oral Capsule	SCD	c6d56d5e-856e-4e48-85f7-fce2beade4d1	4
309114	cephalexin 500 MG Oral Capsule	SCD	c6d56d5e-856e-4e48-85f7-fce2beade4d1	4
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	c6d56d5e-856e-4e48-85f7-fce2beade4d1	4
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	c6d56d5e-856e-4e48-85f7-fce2beade4d1	4
309112	cephalexin 250 MG Oral Capsule	PSN	28da5822-fb0b-1306-e063-6394a90a6e4c	3
309112	cephalexin 250 MG Oral Capsule	PSN	c0ca008e-0e28-412e-a58f-70f63817713b	3
309112	cephalexin 250 MG Oral Capsule	SCD	c0ca008e-0e28-412e-a58f-70f63817713b	3
309112	cephalexin 250 MG Oral Capsule	SCD	28da5822-fb0b-1306-e063-6394a90a6e4c	3
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	c0ca008e-0e28-412e-a58f-70f63817713b	3
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	28da5822-fb0b-1306-e063-6394a90a6e4c	3
309112	cephalexin 250 MG Oral Capsule	PSN	13831529-e814-4b95-9287-c5ba6678bf52	2
309114	cephalexin 500 MG Oral Capsule	PSN	13831529-e814-4b95-9287-c5ba6678bf52	2
309112	cephalexin 250 MG Oral Capsule	SCD	13831529-e814-4b95-9287-c5ba6678bf52	2
309114	cephalexin 500 MG Oral Capsule	SCD	13831529-e814-4b95-9287-c5ba6678bf52	2
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	13831529-e814-4b95-9287-c5ba6678bf52	2
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	13831529-e814-4b95-9287-c5ba6678bf52	2
309112	cephalexin 250 MG Oral Capsule	PSN	30b7071e-cef1-bd41-e063-6394a90ad48e	1
309112	cephalexin 250 MG Oral Capsule	PSN	12cdaf8c-06d1-45f2-b008-2ec33791bbe9	1
309112	cephalexin 250 MG Oral Capsule	PSN	12f78d76-ea13-440c-8dd0-5aec86277acf	1
309112	cephalexin 250 MG Oral Capsule	PSN	216660f3-0329-ef7d-e063-6294a90a17df	1
309114	cephalexin 500 MG Oral Capsule	PSN	12cdaf8c-06d1-45f2-b008-2ec33791bbe9	1
309112	cephalexin 250 MG Oral Capsule	SCD	12cdaf8c-06d1-45f2-b008-2ec33791bbe9	1
309112	cephalexin 250 MG Oral Capsule	SCD	12f78d76-ea13-440c-8dd0-5aec86277acf	1
309112	cephalexin 250 MG Oral Capsule	SCD	216660f3-0329-ef7d-e063-6294a90a17df	1
309112	cephalexin 250 MG Oral Capsule	SCD	30b7071e-cef1-bd41-e063-6394a90ad48e	1
309114	cephalexin 500 MG Oral Capsule	SCD	12cdaf8c-06d1-45f2-b008-2ec33791bbe9	1
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	12cdaf8c-06d1-45f2-b008-2ec33791bbe9	1
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	12cdaf8c-06d1-45f2-b008-2ec33791bbe9	1
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	12f78d76-ea13-440c-8dd0-5aec86277acf	1
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	216660f3-0329-ef7d-e063-6294a90a17df	1
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	30b7071e-cef1-bd41-e063-6394a90ad48e	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Status
65862-018-22	65862001822	2000 CAPSULE in 1 BAG (65862-018-22)	2000 capsule	16-NOV-05	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cephalexin	Preferred Pharmaceuticals Inc.	2026-07-23	HUMAN PRESCRIPTION DRUG LABEL	1
Cephalexin	Bryant Ranch Prepack	2026-04-20	HUMAN PRESCRIPTION DRUG LABEL	100
Cephalexin	REMEDYREPACK INC.	2025-09-30	HUMAN PRESCRIPTION DRUG LABEL	3
Cephalexin	NuCare Pharmaceuticals, Inc.	2025-03-19	HUMAN PRESCRIPTION DRUG LABEL	3
Cephalexin	Coupler, LLC	2025-03-19	HUMAN PRESCRIPTION DRUG LABEL	1
Cephalexin	Bryant Ranch Prepack	2025-01-24	HUMAN PRESCRIPTION DRUG LABEL	1
Cephalexin	Aurobindo Pharma Limited	2024-12-20	Human Prescription Drug Label	18
Cephalexin	A-S Medication Solutions	2024-10-25	Human Prescription Drug Label	17
Cephalexin	A-S Medication Solutions	2024-10-25	Human Prescription Drug Label	14
Cephalexin	NuCare Pharmaceuticals, Inc.	2024-09-05	HUMAN PRESCRIPTION DRUG LABEL	1
Cephalexin	Quality Care Products, LLC \| Lake Erie Medical & Surgical Supply DBA Quality Care Products, LLC	2019-07-22	Human Prescription Drug Label	1
Cephalexin - Blenheim Pharmacal, Inc.	Blenheim Pharmacal, Inc.	2015-03-11	HUMAN PRESCRIPTION DRUG LABEL	4
Cephalexin Capsules, USP	Physicians Total Care, Inc.	2012-08-28	Human Prescription Drug Label	5
CEPHALEXIN - STAT RX USA LLC	STAT RX USA LLC	2010-02-22	HUMAN PRESCRIPTION DRUG LABEL	2
Cephalexin Capsules, USP	Rebel Distributors Corp.	2009-06-01	HUMAN PRESCRIPTION DRUG LABEL	1